Biosynergy Inc (BSYN) Return on Equity ROE from the third quarter 2022 to third quarter 2021 and annually, average high and low, overall ranking from Jan 31 2022 to Jan 31 2021 - CSIMarket
CSIMarket
 


Biosynergy Inc  (BSYN)

Biosynergy Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Biosynergy Inc in the third quarter 2022?
Biosynergy Inc achieved a return on average equity (ROE) of 55.25 % in its third quarter 2022, this is above BSYN's average return on equity of 0%.
Biosynergy Inc shareholder's equity over the 12 months ending in its third quarter 2022 are valued at $1 million

ROE has advanced compared to -3.77% in the second quarter 2022, due to net income growth.

Within the Scientific & Technical Instruments industry Biosynergy Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the second quarter 2022 at no. .

What is ROE?




Return On Equity (Jan 31 2022)
III. Quarter
(Oct 31 2021)
II. Quarter
(Jul 31 2021)
I. Quarter
(Apr 30 2021)
IV. Quarter
(Jan 31 2021)
III. Quarter
Y / Y Equity Change - -3.74 % -3.49 % 0.92 % -
Y / Y Net Income Change - -15.85 % - -91.06 % -
Net Income (TTM) in Millions 1 0 0 0 0
Return On Equity (TTM) 55.25 % -3.77 % -3.47 % 0.91 % 1.57 %
BSYN's Total Ranking # # # # #
Equity (TTM) in Millions 0 2 2 2 2
Seq. Equity Change - 1.38 % -5.1 % 0.06 % -0.01 %
Seq. Net Income Change 3122.41 % - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BSYN Annual Return On Equity (Apr 30 2021)
2021
(Apr 30 2019)
2019
(Apr 30 2017)
2017
(Apr 30 2016)
2016

Total Equity in Millions 2 2 2 1 0
Y / Y Equity Change 2.76 % 6.72 % 7.25 % - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Change -78.51 % -31.47 % 0.89 % - -
Return On Equity 0.91 % 4.34 % 6.76 % 7.19 % -





Annual Roe Comment
In 2021 ROE decreased compared to the previous year to 0.91 %, due to deterioration of net income.


More Return On Equity Ratios
Scientific & Technical Instruments Industry Roe Trends and Statistics
Technology Sector Return On Equity Statistics
BSYN's' Return on Equity at Yahoo Finance
BSYN's Roe Ratio versus Scientific & Technical Instruments Industry, Technology Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BSYN's Competitors
Subscribers only: Roe for Biosynergy Inc's Suppliers
Subscribers only: Return On Equity for BSYN's Customers




Companies with similar Return On Equity at Jan 31 2022, within Technology Sector ROE
Gartner Inc   149.39 %
Netapp Inc   142.08 %
Silicon Laboratories Inc   116.11 %
Adtheorent Holding Company Inc   115.40 %
Qualcomm Inc  112.53 %
Mandiant Inc.  105.12 %
Symbolic Logic Inc   104.37 %
Kla Corporation  87.04 %
Alpha And Omega Semiconductor Limited  85.65 %
Citrix Systems Inc.  82.58 %
Extreme Networks Inc   73.63 %
Dell Technologies Inc   73.30 %
Arbe Robotics Ltd  72.78 %
Tsr Inc   72.43 %
Sohu com Limited  72.29 %
A10 Networks Inc   69.49 %
Bluecity Holdings Limited  69.43 %
Texas Instruments Incorporated  66.40 %
Sidechannel Inc   61.58 %
Fortinet Inc   61.21 %
Gse Systems Inc   60.49 %
Aviat Networks Inc   58.92 %
Intellinetics Inc   56.32 %
Shopify Inc   54.39 %
Applied Materials Inc  53.97 %
3d Systems Corporation  51.12 %
Microsoft Corporation  49.91 %
Himax Technologies Inc   49.76 %
Automatic Data Processing Inc   49.07 %
Manhattan Associates Inc   48.75 %


Date modified: 2026-09-26T07:25:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.